In this study, our observations indicated that niclosamide can inhibit breast cancer migration and invasion in vitro by down-regulating FAK phosphorylation at tyrsion residue 925 and Src- phosphorylation at tyrsion residue 416. The gene discussed is SRC; the disease is breast carcinoma.